Cell of origin of transformed follicular lymphoma

Anderson, 1998, Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project., Ann Oncol, 9, 717, 10.1023/A:1008265532487 Junlén, 2015, Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study., Leukemia, 29, 668, 10.1038/leu.2014.251 Bachy, 2013, Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma., Haematologica, 98, 1107, 10.3324/haematol.2012.082412 Al-Tourah, 2008, Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma., J Clin Oncol, 26, 5165, 10.1200/JCO.2008.16.0283 Link, 2013, Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource., J Clin Oncol, 31, 3272, 10.1200/JCO.2012.48.3990 Montoto, 2007, Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma., J Clin Oncol, 25, 2426, 10.1200/JCO.2006.09.3260 Bastion, 1997, Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients., J Clin Oncol, 15, 1587, 10.1200/JCO.1997.15.4.1587 Lossos, 2011, Transformation of follicular lymphoma., Best Pract Res Clin Haematol, 24, 147, 10.1016/j.beha.2011.02.006 Lerch, 2015, Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis., Ann Hematol, 94, 981, 10.1007/s00277-015-2303-5 Giné, 2006, The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma., Ann Oncol, 17, 1539, 10.1093/annonc/mdl162 Akasaka, 2003, BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma., Blood, 102, 1443, 10.1182/blood-2002-08-2482 Do, 2003, Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma., Leuk Lymphoma, 44, 1317, 10.1080/1042819031000090228 Pasqualucci, 2014, Genetics of follicular lymphoma transformation., Cell Reports, 6, 130, 10.1016/j.celrep.2013.12.027 Cheung, 2009, Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances., Blood, 113, 137, 10.1182/blood-2008-02-140616 Carlotti, 2009, Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone., Blood, 113, 3553, 10.1182/blood-2008-08-174839 Okosun, 2014, Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma., Nat Genet, 46, 176, 10.1038/ng.2856 O’Shea, 2009, Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation., Blood, 113, 2298, 10.1182/blood-2008-08-174953 Yano, 1992, MYC rearrangements in histologically progressed follicular lymphomas., Blood, 80, 758, 10.1182/blood.V80.3.758.758 Lossos, 2002, Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes., Proc Natl Acad Sci USA, 99, 8886, 10.1073/pnas.132253599 Lo Coco, 1993, p53 mutations are associated with histologic transformation of follicular lymphoma., Blood, 82, 2289, 10.1182/blood.V82.8.2289.2289 Sander, 1993, p53 mutation is associated with progression in follicular lymphomas., Blood, 82, 1994, 10.1182/blood.V82.7.1994.1994 Fitzgibbon, 2007, Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma., Leukemia, 21, 1514, 10.1038/sj.leu.2404696 Davies, 2007, Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms., Br J Haematol, 136, 286, 10.1111/j.1365-2141.2006.06439.x Davies, 2005, A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma., Leukemia, 19, 1459, 10.1038/sj.leu.2403802 Wright, 2003, A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma., Proc Natl Acad Sci USA, 100, 9991, 10.1073/pnas.1732008100 Bouska, 2014, Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma., Blood, 123, 1681, 10.1182/blood-2013-05-500595 Johnson, 2009, Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival., Blood, 114, 2273, 10.1182/blood-2009-03-212191 Kanungo, 2006, Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis., Mod Pathol, 19, 25, 10.1038/modpathol.3800500 Barrans, 2010, Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab., J Clin Oncol, 28, 3360, 10.1200/JCO.2009.26.3947 Dunleavy, 2009, Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma., Blood, 113, 6069, 10.1182/blood-2009-01-199679 Nowakowski, 2015, Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study., J Clin Oncol, 33, 251, 10.1200/JCO.2014.55.5714 Wilson, 2015, Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma., Nat Med, 21, 922, 10.1038/nm.3884 Hans, 2004, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray., Blood, 103, 275, 10.1182/blood-2003-05-1545 Scott, 2014, Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue., Blood, 123, 1214, 10.1182/blood-2013-11-536433 Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform., Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 Koboldt, 2009, VarScan: variant detection in massively parallel sequencing of individual and pooled samples., Bioinformatics, 25, 2283, 10.1093/bioinformatics/btp373 Koboldt, 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing., Genome Res, 22, 568, 10.1101/gr.129684.111 Kridel, 2012, Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma., Blood, 119, 1963, 10.1182/blood-2011-11-391474 Gray, 2009, Weighted analyses for cohort sampling designs [published correction appears in Lifetime Data Anal. 2009;15(3):411]., Lifetime Data Anal, 15, 24, 10.1007/s10985-008-9095-z Scott, 2015, Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies [published online ahead of print August 3, 2015]., J Clin Oncol, 10.1200/JCO.2014.60.2383 van Dongen, 2003, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936., Leukemia, 17, 2257, 10.1038/sj.leu.2403202 Rosenwald, 2002, The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma., N Engl J Med, 346, 1937, 10.1056/NEJMoa012914 Lenz, 2008, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma., Science, 319, 1676, 10.1126/science.1153629 Davis, 2010, Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma., Nature, 463, 88, 10.1038/nature08638 Ngo, 2011, Oncogenically active MYD88 mutations in human lymphoma., Nature, 470, 115, 10.1038/nature09671 Bohers, 2014, Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma., Genes Chromosomes Cancer, 53, 144, 10.1002/gcc.22126 Klein, 2006, Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination., Nat Immunol, 7, 773, 10.1038/ni1357 Ochiai, 2013, Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4., Immunity, 38, 918, 10.1016/j.immuni.2013.04.009 Willis, 2014, Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism., J Immunol, 192, 3200, 10.4049/jimmunol.1303216 Natkunam, 2001, Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry., Mod Pathol, 14, 686, 10.1038/modpathol.3880373 Sweetenham, 2010, Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study., Ann Oncol, 21, 1196, 10.1093/annonc/mdp460 Xerri, 2014, Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis., Hum Pathol, 45, 2085, 10.1016/j.humpath.2014.06.019 Yang, 2012, Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma., Cancer Cell, 21, 723, 10.1016/j.ccr.2012.05.024 Madsen, 2015, Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation., Ann Oncol, 26, 393, 10.1093/annonc/mdu537 Cunningham, 2013, Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles., Lancet, 381, 1817, 10.1016/S0140-6736(13)60313-X Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling., Nature, 403, 503, 10.1038/35000501 Monti, 2005, Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response., Blood, 105, 1851, 10.1182/blood-2004-07-2947 Dybkær, 2015, Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis., J Clin Oncol, 33, 1379, 10.1200/JCO.2014.57.7080 Lenz, 2008, Stromal gene signatures in large-B-cell lymphomas., N Engl J Med, 359, 2313, 10.1056/NEJMoa0802885 Leich, 2009, Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations., Blood, 114, 826, 10.1182/blood-2009-01-198580 Karube, 2007, CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features., Blood, 109, 3076, 10.1182/blood-2006-09-045989